GlassScriptPhysician profile
Kathleen E Hemschoot
NPI 1891132684
$8,829.40
in general payments reported to CMS, 2019-2025
31 companies · $1,551 in 2025
The $1,551 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,665 · 2022: $2,102 · 2023: $1,740 · 2024: $1,772 · 2025: $1,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,062.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,674.13 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,663.06 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,246.68 | 2021-2025 | |
| Glaxosmithkline, LLC. | $754.63 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $683.30 | 2022-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $425.21 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.37 | 2021-2025 | Jardiance |
| Pfizer INC. | $320.09 | 2021-2024 | |
| Kowa Pharmaceuticals America, INC. | $271.30 | 2021-2024 | Livalo, Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $226.44 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $167.52 | 2024-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $158.50 | 2022-2024 | Eliquis |
| Amarin Pharma, INC. | $141.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $93.61 | 2021 | |
| Idorsia Pharmaceuticals US INC | $88.38 | 2022-2023 | Quviviq |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $87.30 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $67.60 | 2021-2022 | |
| Astellas Pharma US INC | $61.98 | 2023-2024 | Veozah, Myrbetriq |
| Becton, Dickinson and Company | $57.55 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.85 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $43.02 | 2024-2025 | Voquezna |
| Paratek Pharmaceuticals, INC. | $40.41 | 2021 | |
| Ibsa Pharma INC. | $27.22 | 2022-2025 | Licart, Flector, Tirosint |
| Acadia Pharmaceuticals INC | $26.62 | 2021 | |
| Depuy Synthes Sales INC. | $21.48 | 2024 | Monovisc, Orthovisc |
| Cumberland Pharmaceuticals, INC. | $21.36 | 2025 | Kristalose |
| Renalytix Ai, INC. | $19.50 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Seqirus USA INC | $18.65 | 2025 | Flucelvax, Fluad |
| Novartis Pharmaceuticals Corporation | $15.96 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.62 | 2022 | |
| Genentech USA, INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Hemschoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.